HEADWAY
A new roapmap in Brain Health

Focus Epilepsy

Description of the initiative

“Headway – A new roadmap for Brain Health: Focus Epilepsy” was conceived and launched at the beginning of 2022 by the Think Tank The European House – Ambrosetti in partnership with Angelini Pharma with the aim of creating an expert panel for strategic reflection, analysis, dialogue and comparison between various European experiences in the management of individuals with Epilepsy.

The scope of the initiative is to share knowledge and know-how to prevent, diagnose, manage, and find solutions that reduce the burden of Epilepsy not only in the healthcare sector, but also in workplaces, schools and society in general.

The initiative keeps the trajectory and works in continuity and coherence with programs, activities and strategies of Governments and International Organizations (such as the WHO) and scientific societies / patient associations / advocacy groups (among others, ILAE, IBE and Epilepsy Alliance Europe), as well as of European Institutions, with the objective of contributing to reducing the burden of Epilepsy in Europe.

The specific aims include:

• To increase knowledge and awareness of the critical issues/specificities related to Epilepsy among policy makers, media and the general public, outlining the current scenario in Europe and elaborate reflections on the impacts of Epilepsy with a particular focus on health and quality of life;
• Create benchmarks to compare policies and action plans developed and implemented across Europe;
• Formulate policy recommendations to promote good health for people with Epilepsy;
• Stimulate debate among relevant stakeholders (including policy makers, institutions, patient and caregiver associations, clinicians, health economists, etc.);
• Communicate and disseminate the results of the initiative and its proposals for action and raise awareness at European level.